Investors Asset Management of Georgia’s Zimmer Biomet ZBH Stock Holding History

Investors Asset Management of Georgia’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10	Closed	-$1K	–	546
2022 Q3	$1K	Hold	10	–	–	﹤0.01%	607
2022 Q2	$1K	Buy	+10	New	+$1.19K	﹤0.01%	571

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Investors Asset Management of Georgia's ZBH Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 10 shares — an estimated $1K sold.

Investors Asset Management of Georgia first reported a position in ZBH in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 978 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Investors Asset Management of Georgia reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
Investors Asset Management of Georgia sold 10 Zimmer Biomet shares in Q4 2022, an estimated $1K.
Investors Asset Management of Georgia first reported a position in Zimmer Biomet in Q2 2022 and held it in 2 quarters.
Investors Asset Management of Georgia's Zimmer Biomet position peaked at $1K in Q3 2022.
978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.